Treatment with hemin — an iron-containing medication derived from red blood cells — effectively reduced the frequency of symptomatic attacks in a middle-aged woman with acute intermittent porphyria (AIP), and also mitigated a decline in her kidney function. According to the researchers, the use of hemin, sometimes prescribed for…
Discussion
Acute intermittent porphyria (AIP) is associated with a higher prevalence of high blood pressure (hypertension) and heart structural changes, according to a recent study. The results suggest that age, body mass index (BMI) — a measure of body fat based on a weight-to-height ratio — and a history of…
Discussion
The experimental drug bitopertin is now available through an expanded access program for eligible patients aged 12 and older with erythropoietic protoporphyria (EPP), allowing them to receive the oral treatment while it continues to be tested in late-stage clinical studies. “Recognizing the urgent need for new treatment options for…
Discussion
The Global Porphyria Advocacy Coalition (GPAC) announced that an international database focused on the safety of medications for people with acute porphyria is now available in Spanish. People with certain types of porphyria may experience attacks of worsening symptoms after using certain commonly prescribed medications. The Norwegian…
Becoming educated and informed about porphyria is a good first step. Here you’ll find general information about the disease, including the types, diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of some of our columnist’s words of wisdom to help you along on your porphyria journey.
There is no cure for porphyria yet, but there are therapies that can help manage the disease. Here you can find more information about some of the approved treatments for porphyria.
Get regular updates to your inbox.
